These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37256580)

  • 1. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
    Braga J; Lepra M; Kish SJ; Rusjan PM; Nasser Z; Verhoeff N; Vasdev N; Bagby M; Boileau I; Husain MI; Kolla N; Garcia A; Chao T; Mizrahi R; Faiz K; Vieira EL; Meyer JH
    JAMA Psychiatry; 2023 Aug; 80(8):787-795. PubMed ID: 37256580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
    Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
    JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.
    Attwells S; Setiawan E; Wilson AA; Rusjan PM; Mizrahi R; Miler L; Xu C; Richter MA; Kahn A; Kish SJ; Houle S; Ravindran L; Meyer JH
    JAMA Psychiatry; 2017 Aug; 74(8):833-840. PubMed ID: 28636705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.
    Setiawan E; Attwells S; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Xu C; Sharma S; Kish S; Houle S; Meyer JH
    Lancet Psychiatry; 2018 Apr; 5(4):339-347. PubMed ID: 29496589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.
    Attwells S; Setiawan E; Rusjan PM; Xu C; Hutton C; Rafiei D; Varughese B; Kahn A; Kish SJ; Vasdev N; Houle S; Meyer JH
    Biol Psychiatry; 2020 Oct; 88(8):649-656. PubMed ID: 32402468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrogliosis Marker [
    Braga J; Kuik EJY; Lepra M; Rusjan PM; Kish SJ; Vieira EL; Nasser Z; Verhoeff N; Vasdev N; Chao T; Bagby M; Boileau I; Kloiber S; Husain MI; Kolla N; Koshimori Y; Faiz K; Wang W; Meyer JH
    Biol Psychiatry; 2024 Oct; ():. PubMed ID: 39395470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy.
    Li H; Sagar AP; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():1-7. PubMed ID: 29269262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder.
    Attwells S; Setiawan E; Rusjan PM; Xu C; Kish SJ; Vasdev N; Houle S; Santhirakumar A; Meyer JH
    Transl Psychiatry; 2021 May; 11(1):334. PubMed ID: 34052828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
    Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.
    Da Silva T; Hafizi S; Watts JJ; Weickert CS; Meyer JH; Houle S; Rusjan P; Mizrahi R
    JAMA Psychiatry; 2019 Dec; 76(12):1305-1313. PubMed ID: 31532458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicating predictive serum correlates of greater translocator protein distribution volume in brain.
    Attwells S; Setiawan E; Wilson AA; Rusjan PM; Miler L; Xu C; Hutton C; Husain MI; Kish S; Vasdev N; Houle S; Meyer JH
    Neuropsychopharmacology; 2020 May; 45(6):925-931. PubMed ID: 31683271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder.
    Li H; Sagar AP; Kéri S
    J Affect Disord; 2018 Dec; 241():305-310. PubMed ID: 30142589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.
    Rekkas PV; Wilson AA; Lee VW; Yogalingam P; Sacher J; Rusjan P; Houle S; Stewart DE; Kolla NJ; Kish S; Chiuccariello L; Meyer JH
    JAMA Psychiatry; 2014 Aug; 71(8):873-9. PubMed ID: 24898155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
    Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
    Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
    Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging translocator protein (TSPO) in autism spectrum disorder.
    Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM
    Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSPO expression and brain structure in the psychosis spectrum.
    Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
    Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-associated changes in longitudinal [
    De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
    Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.